Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rethink Ed is a comprehensive digital platform providing evidence-based behavioral health and special education solutions for K-12 schools and districts. A division of Rethink First, the company offers a suite of tools including social-emotional learning (SEL) curricula, professional development for educators, and data-tracking software for students with neurodevelopmental disorders such as Autism. Their services aim to support the academic, behavioral, and mental health needs of all students while empowering educators with clinical-grade resources. The platform is widely used across the United States to improve outcomes for students with diverse learning needs. By integrating clinical best practices into the classroom, Rethink Ed helps schools manage complex behavioral challenges and foster inclusive learning environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rethink Ed.